Description
Vibrenta Penset 3 ml is a long-acting insulin formulation containing 100 IU/ml of insulin glargine, a recombinant human insulin analogue produced by Incepta Pharmaceuticals Ltd. Designed for subcutaneous injection, it provides a steady, peakless insulin effect lasting up to 24 hours, making it suitable for once-daily administration. This insulin is primarily used to improve glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. It works by facilitating glucose uptake into muscle and fat cells while suppressing liver glucose production. Vibrenta Penset is not intended for intravenous use and should not be mixed with other insulins. Common side effects include hypoglycemia, allergic reactions, and injection site reactions. It is essential to rotate injection sites and monitor blood glucose levels regularly to adjust dosages appropriately. The product is available in a 3 ml cartridge format, compatible with insulin pens designed for such cartridges
.jpeg)
.jpeg)
.jpg)
.jpeg)
.jpg)
.jpg)
.jpg)
.webp)
 400MG.jpg)
.jpg)
.jpg)
 100 IU 3 ML.webp)
.jpg)
.jpeg)
.png)
.jpg)
.webp)
.webp)
Change Language